News that Walgreens quarterly loss was better than expected and pharmacy sales were rising bodes well for a turnaround under ...

Walgreens Boots Alliance , which is being taken private by Sycamore Partners, beat analysts' estimates for third-quarter ...

Store closures and weak front-of-store comps led to a retail sales decline in Q3, but U.S. pharmacy and international sales ...

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement ...

Walgreens posted quarterly earnings that beat analyst expectations this morning, a potentially positive sign before going ...

Walgreens' results beat Wall Street expectations, based on a survey of analysts by LSEG. The company reported adjusted ...

Walgreens faces a potential buyout by Sycamore Partners amid declining profits and heavy debt. Click here to read my earnings ...

As Walgreens goes private in a $10 billion buyout, experts weigh what private equity ownership could mean for pharmacy care.

Walgreens is addressing the challenging retail sales environment by focusing on value. Earlier in June, the company rolled ...

Walgreens in March agreed to be taken private by PE firm Sycamore Partners for $10 billion, closing out nearly a century of trading on public markets for the U.S. pharmacy giant.

It’s one of the last financial reports for Walgreens before it transitions to a private company in a deal with private equity firm Sycamore Partners. Walgreens also withdrew its 2025 financial ...

Walgreens in March agreed to be taken private by PE firm Sycamore Partners for $10 billion, closing out nearly a century of trading on public markets for the U.S. pharmacy giant.